Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

University Park, Pennsylvania 16802


Purpose:

The investigators will conduct a small-scale randomized control trial comparing the intervention game to an active control game, and will assess outcomes at multiple time points (pre-, post-, 6-month follow-up). These outcomes will include a wide range of behaviors that are measured along a continuum from controlled lab-based tasks to uncontrolled, real-world social interactions between dyads.


Study summary:

The investigators will conduct a small-scale randomized control trial comparing the intervention game to an placebo control game, and will assess outcomes at multiple time points (pre-, post-, 6-month follow-up). These outcomes will include a wide range of behaviors that are measured along a continuum from controlled lab-based tasks to real-world social interactions between dyads. The aims are evaluating 1) changes in the target mechanisms (social attention to faces, sensitivity to eye gaze cues) for the intervention relative to active control group, 2) engagement of intermediate mechanisms, including face-processing behaviors and real-world social communication behaviors, and 3) the relation between engagement of the target and intermediate mechanisms and symptom outcomes. Evidence of changes in autism social symptoms resulting from changing visual attention to faces and/or improved ability to understand eye gaze cues will provide clear evidence to inform a "go" decision about the therapeutic target for further clinical development.


Criteria:

Inclusion Criteria: 1. parent/caregiver of an adolescent with a diagnosis of autism spectrum disorder (ASD), 2. parent/caregiver and adolescent with ASD both native English speakers, 3. adolescent with ASD aged between 10-18 years at pre-test, 4. adolescent has normal vision and hearing with correction as reported by caregiver, 5. adolescent is able to use a computer for the purposes of game play, 6. adolescent scores < 80% correct (i.e., 0.5 SD less than Mean of typically developing adolescents) on online eye gaze screening task, 7. ASD diagnosis of adolescent confirmed in lab via the Autism Diagnostic Observation Schedule (ADOS-2); 8. Full Scale IQ of adolescent determined to be between 70-130; 9. reading ability of adolescent determined to be at least a 2nd grade level; 10. adolescent is capable of cooperating with testing; 11. parent/caregiver and adolescent both consent/assent to participate in the research. Exclusion Criteria: 1. having seizures within the previous two years 2. no stable internet connection in the home 3. refusing to consent/assent to take part in the research 4. 18 and have a legal guardian, which prohibits them from legally consenting for themselves 5. 18 and cannot understand the consent as indicated by failing a quiz prior to signing the consent.


NCT ID:

NCT03690661


Primary Contact:

Principal Investigator
Suzy Scherf
Penn State University

Suzy Scherf
Phone: 814-867-2921
Email: suzyscherf@psu.edu


Backup Contact:

N/A


Location Contact:

University Park, Pennsylvania 16802
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.